Toll-like receptor 9 (TLR9) recognizes DNA containing CpG motifs derived from bacteria and viruses and activates the innate immune response to eliminate them. TLR9 is known to bind to CpG DNA, and here, we identified another DNA binding site in TLR9 that binds DNA containing cytosine at the second position from the 5 0 end (5 0 -xCx DNA). 5 0 -xCx DNAs bound to TLR9 in the presence of CpG DNA and cooperatively promoted dimerization and activation of TLR9. Binding at both sites was important for efficient activation of TLR9. The 5 0 -xCx DNA bound the site corresponding to the nucleoside binding site in TLR7 and TLR8 as revealed by the structural analysis. This study revealed that TLR9 recognizes two types of DNA through its two binding sites for efficient activation. This information may contribute to the development of drugs that control the activity of TLR9.
INTRODUCTION
The immune system is involved in biological defense following the invasion of pathogens. Innate immunity lies at the forefront of this process and rapidly senses the invasion of pathogens and elicits an early immune response. Molecules derived from microorganisms and viruses, such as pathogen-associated molecular patterns (PAMPs), are recognized by a variety of pattern-recognition receptors (PRRs) including Toll-like receptors (TLRs), nucleotide-binding oligomerization domain-containing-like receptors, and retinoic acid-inducible gene-I-like receptors that function in the innate immunity system to stimulate these early immune responses (Takeuchi and Akira, 2010 ) (Palm and Medzhitov, 2009 ). Thus far, a variety of PAMPs have been identified, among them nucleic acids, such as pathogenderived DNAs and RNAs, which constitute a large subset of PAMPs that can activate PRRs and cause the production of type-I interferon and pro-inflammatory cytokines to defend against the invading pathogens ( Barbalat et al., 2011) . As all organisms have nucleic acids, and to avoid unsolicited immune responses by self-derived nucleic acids, the recognition of nucleic acids derived from pathogens must be precisely controlled using multi-level regulation mechanisms such as a cellular localization of nucleic acids and PRRs, processing of nucleic acids, post-transcriptional processing of PRRs, and direct interaction between nucleic acids and PRRs (Crowl et al., 2017; Roers et al., 2016; Sparrer and Gack, 2015; Wu and Chen, 2014 ) (Miyake et al., 2017) . The failure of these regulation mechanisms often leads to autoimmune diseases and therefore PRRs involved in the nucleic acids recognition are considered as a potential target for therapeutic agents to treat these diseases (Crowl et al., 2017; Wu and Chen, 2014) (Barbalat et al., 2011) . TLRs are single transmembrane receptors and among the TLRs, TLR3, TLR7, TLR8, TLR9, and TLR13 (mouse specific) are localized in the endosomal compartment and are involved in the recognition of nucleic acids (O'Neill et al., 2013) . TLR3 is responsible for the recognition of double-stranded RNA (Alexopoulou et al., 2001 ), TLR7 and TLR8 for single-stranded RNA (Diebold et al., 2004; Heil et al., 2004; Lund et al., 2004) , TLR9 for single-stranded DNA having a cytosine-phosphate-guanine (CpG) dideoxynucleotide motif (Hemmi et al., 2000) , and TLR13 for bacterial 23S ribosomal RNA (Li and Chen, 2012; Oldenburg et al., 2012) . TLR7, TLR8, and TLR9 therefore form a TLR7 subfamily that recognizes single-stranded nucleic acids (Roach et al., 2005) . The extracellular domain of the TLR7 subfamily members consists of the same number of leucine-rich repeats (LRRs), LRR1-26, and furthermore between LRR14 and LRR15 there is a long loop region of 40-50 residues called the Z-loop (Ohto et al., 2014) . Several biochemical and structural studies have demonstrated that cleavage of the Z-loop is essential for activation of the TLR7 subfamily Ewald et al., 2008; Hipp et al., 2013; Ishii et al., 2014; Miyake et al., 2017; Park et al., 2008; Sepulveda et al., 2009) . Recently, we determined the crystal structure of the extracellular domain of TLR9 and the dimer structure of its complex with a 12-mer DNA molecule containing a CpG motif (DNA1668_12-mer: CATGACGTTCCT) , where the bases in the CpG motif bind into the groove formed by the N-terminal side of one TLR9 protomer, while another protomer (TLR9*, where the asterisk identifies the second protomer in the dimer; this terminology is used throughout this paper) simultaneously recognizes the phosphate backbone portion of the CpG motif from the opposite side, and induces dimerization of TLR9. It has been shown that DNA molecules with a length between 20 to 30 nucleotides having a TCG or TCC sequence at the 5 0 end of the molecule in addition to the CpG motif (e.g., minH75 DNA for human TLR9: 5 0 -TCGT 7 CGT 12 [Pohar et al., 2015a] [Pohar et al., 2015b] ) more efficiently activate TLR9 than DNAs lacking the 5 0 -TCG or TCC sequences, suggesting that bases at the 5 0 end also play important roles in TLR9 activation. In addition, a short ssDNA containing a 5 0 -TCG motif was reported to augment CpG-containing DNA-induced TLR9 activation (Pohar et al., 2017a) . This indicated that TLR9 has additional DNA binding sites other than the binding site for the CpG motif. Of particular interest, other members of the TLR7 subfamily, including TLR7 and TLR8, can recognize two different ligands, single-stranded RNA and mononucleosides (guanosine for TLR7, uridine for TLR8), simultaneously at distinct sites and the two ligand binding sites cooperatively function in dimerization of TLR7 and TLR8 Zhang et al., 2016) . Based on the functional and structural homology among the TLR7 subfamily members, it is expected that TLR9 also contains multiple ligand binding sites, similar to TLR7 and TLR8. However, its specific binding sites and their role in ligand induced activation of TLR9 have not been determined.
In this study, we have identified a second DNA binding site in TLR9 from a structural analysis, and from various biochemical, biophysical, and cell biological analyses, we demonstrated that binding of DNA to this site promotes TLR9 dimerization in cooperation with the CpG motif. We also identified the sequence requirements for this second DNA binding site in TLR9. These findings may be useful in the development of drugs that control the activity of TLR9.
RESULTS

The 5
0 -xCx and CpG DNAs Simultaneously Bind to TLR9 to Promote Dimerization We have previously demonstrated that CpG DNA binding to the N-terminal groove of TLR9 induces dimerization . On the other hand, recent reports have predicted the existence of another DNA binding site and that both sites are important for efficient TLR9 activation (Pohar et al., 2015a; Pohar et al., 2015b; Pohar et al., 2017b) . We predicted that the second DNA binding site in TLR9 might accommodate 5 0 -TCG or 5 0 -TCC DNA motifs (Pohar et al., 2015a; Pohar et al., 2015b) . To test this idea, we conducted isothermal titration calorimetry (ITC) analyses using two types of DNA: a 10-mer CpG-containing DNA (AGGCGTTTTT) targeting the previously identified CpG binding site in TLR9, and a 6-mer 5 0 -TCG-containing DNA (TCGCCC) targeting the second binding site of TLR9 (Table 1) , whose binding sites were verified by the structural study discussed later. Highaffinity binding was confirmed for all species of TLR9 tested with the CpG-containing DNA alone: the Kds for AGGCGTTTTT were 97 nM, 320 nM, and 21 nM for horse (Equus caballus; Ec), bovine (Bos Taurus; Bt), and MmTLR9, respectively (Table 1, Figure S1 ). On the other hand, no binding of the 5 0 -TCG-containing DNA to any species of TLR9 was observed. However, the 5 0 -TCG-containing DNA bound to TLR9 with high affinity in the presence of the CpG-containing DNA: the Kds for the 5 0 -TCG-containing DNA were 21 nM, 44 nM, and 7 nM for EcTLR9, BtTLR9, and MmTLR9, respectively (Table 1) . We also conducted gelfiltration chromatography using a 10-mer CpG-containing DNA (AGGCGTTTTT) and a 6-mer 5 0 -TCG-containing DNA (Figure 1 ). The CpG-containing DNA and the 5 0 -TCG-containing DNA bound simultaneously to TLR9, as judged by an increase of the ratio of absorbances at 260 nm and 280 nm, compared with the ratio seen with the CpG-containing DNA alone (Figure 1) . Binding of the 5 0 -TCG-containing DNA TLR9 promoted dimerization in the presence of the CpG-containing DNA (Figure 1) . We have previously demonstrated that the CpG-containing DNA can promote the dimerization of TLR9 but required high concentrations of TLR9 and the CpG-containing DNA: for example, the Kd value for the dimerization of EcTLR9 induced by DNA1668_12-mer, determined by analytical ultracentrifugation analysis, was found to be 20 mM . Therefore, dimerization could only be observed in experiments where high concentration of TLR9 and the CpG DNA ligand could be achieved, such as during ultracentrifugation or crystallography, but not for example during gel-filtration chromatography using EcTLR9 or BtTLR9 . However, because of the simultaneous binding of the two DNAs, TLR9, even from EcTLR9 or BtTLR9, was found to elute at a position during gelfiltration chromatography that indicated dimerization had occurred ( Figures 1A and 1B) . Interestingly, the dimerization of mouse TLR9 could be observed during gel-filtration using the CpG-containing DNA alone, indicating that mouse TLR9 forms a more stable dimer than other species of TLR9 ( Figure 1C ). Figure S1 .
These results demonstrated that TLR9 contained two DNA binding sites, the CpG DNA site and a 5 0 -TCG DNA binding site, and that they contributed cooperatively to TLR9 dimerization.
The Second Position Cytosine from the 5 0 End Is Important for TLR9 Binding The nucleotide sequence specificity of the 5 0 -TCG DNA binding site in TLR9 was studied using 5 0 -TCG DNA variants in which each of three positions from the 5 0 side of 6-mer 5 0 -TCG DNA (TCGCCC) were changed. DNA binding to TLR9 was measured by ITC in the presence or absence of a 10-mer CpG containing DNA (AGGCGTTTTT) ( Table 1 ). In the presence of the CpG-containing DNA, most of the first position variants of the 5 0 -TCG DNAs exhibited high affinity binding to EcTLR9, BtTLR9, and MmTLR9, although the base at the 5 0 end disfavors adenine, and species differences were observed (Table 1 ). In contrast, for the second position variants in the 5 0 -TCG DNA, binding to TLR9 was either not observed at all or was greatly attenuated, even in the presence of the CpG-containing DNA molecule. Likewise, binding was not observed when the CG sequence was swapped with GC or TGCCCC or when an additional base was appended to the 5 0 position of TCGCCC, to give TTCGCCC for example, further confirming the importance of the cytosine in the second position from the 5 0 end. The third position variants exhibited similar binding affinities as the wild-type molecules. The addition of a phosphate group to the 5 0 end of TCGCCC, to produce p-TCGCCC, greatly reduced the binding affinity, whereas the addition of a phosphate to the 3 0 end did not affect binding affinity. Furthermore, the methylation of cytosine at the second position in the 5 0 -TCG DNA resulted in reduced affinity. Next, the effect of these 5 0 -TCG DNA variants on dimerization of TLR9 was examined by gel filtration chromatography (Figure S2) . Consistently, we obtained results that corresponded well to the results obtained with ITC. Dimerization was observed in the presence of most of the DNAs containing the first and third position variations ( Figure S2 ). In contrast, no dimerization was observed in the presence of DNAs having bases other than cytosine at the second position, because they do not bind TLR9 as determined by ITC ( Table 1 ). Note that dimerization of mouse TLR9 could be induced in the presence of a 10-mer CpG-containing DNA by itself, and thus dimerization resulting from the cooperativity of the 5 0 -TCG DNA variants was not apparent in this assay for this species. In addition, DNA molecules containing the TGCCCC sequence or the TC(met)GCCC sequence (i.e., containing a methylated cytosine), caused either a complete abolition of dimerization or a decrease in dimerization, respectively.
In summary, these data reveal that DNAs with a cytosine nucleotide at the second position from the 5 0 end (5 0 -xCx DNA) bind strongly to TLR9, and this binding is highly coupled with TLR9 dimerization.
Structure of the Second DNA Binding Site of TLR9
To understand the mechanism underlying the synergistic effect of the CpG DNA and 5 0 -xCx DNA on TLR9 dimerization, we determined the crystal structure of the EcTLR9 in complex with a 10-mer CpG-containing DNA (CpG1: AGGCGTTTTT) and a 6-mer 5 0 -xCx-containing DNA (5 0 -xCx1: TCGCAC), which revealed a symmetric 2:2:2 complex (Table 2, Figure 2A , Figure S3 , S4). The electron density for both DNA molecules were visible at two distinct sites ( Figure S3A , top). The dimer structure of TLR9 in the 2:2:2 complex was essentially the same as the 2:2 complex of TLR9 and DNA1668_12-mer containing the CpG motif (Figure S3B, left) . The CpG1 motif bound at the N-terminal CpG binding groove of TLR9 through the essentially the same interactions as reported previously ( Figure 2B Gel-filtration chromatography analysis of EcTLR9 (A), BtTLR9 (B), and MmTLR9 (C). TLR9 alone (black), with CpG-containing DNA (orange), with TCG-containing DNA (green), and with both DNAs (blue) were analyzed. Gelfiltration chromatography was performed using a Superdex 200 Increase 10/300 GL column (GE Healthcare) in a running buffer (25 mM MES-NaOH pH 5.5 and 250 mM NaCl) at a flow rate of 1 mL/min. The sample containing 1 mM TLR9, with or without the 2 mM indicated DNAs (total volume, 200 mL), was injected and the eluate was monitored for absorbances at 260 nm and 280 nm. The ratio of the absorbances at 260 and 280 nm is indicated above each peak. See also Figure S2 .
nucleotides of the 5 0 -xCx1-containing DNA (T1, C2, and G3) made contacts with TLR9 ( Figure 2C ). The T1 nucleotide was located on the convex surface of LRR18* and LRR19* and was wedged among the Asn567*-linked N-glycan (LRR18*), the loop region of LRR8, the side chains of Tyr345 (LRR11) and Phe375 (LRR12), and the loop region of LRR8. The 5 0 OH group of T1 made hydrogen bonds with D259 (LRR8) and Tyr345 (LRR11). The phosphate group between T1 and C2 (P1-2) hydrogen bonded to the main chain NH group of Lys348 (LRR11) and the side chain OH group of Tyr536* (LRR17). The second nucleotide, C2, which was positioned at exactly the same place as guanosine (TLR7) and uridine (TLR8), was located between LRR11-13 and LRR17*-18*, and made multiple interactions with TLR9 and TLR9* ( Figure 2E ). The N3 and N4 atoms made hydrogen bonds with the side chain of Asp534* (LRR17*) with good geometry. The N4 also formed a hydrogen bond with the main chain O atom of Gly565 (LRR18*). In addition, the C2 base was sandwiched by Phe402 (LRR13) and Tyr536* (LRR17*). The P2-3 phosphate group hydrogen bonded to Ser350 (LRR11). The third nucleotide G3 made contacts with only one protomer TLR9: the base moiety of G3 was located on the convex surface of LRR11 and made hydrogen bonds with the main chain N of Ala352 and the side chain of Arg377.
The remaining region of the 5 0 -xCx1 DNA (C4, A5, and C6) protruded from the dimer structure of TLR9, and thus does not contribute to TLR9 binding and dimerization ( Figure 2A ). Consistent with the results of ITC and gel filtration chromatography (Table 1, Figure S2 ), the C2 base in the second position from the 5 0 end was strictly recognized in the structure, while the first and third positions were relatively loosely recognized.
We also determined the structures of EcTLR9 in complex with the same CpG-containing DNA and two DNAs having variations at the first position of the 6-mer, namely 5 0 -xCx DNA, 5 0 -xCx2: GCGCAC and 5 0 -xCx3: CCGCAC, and of the BtTLR9 in complex with a 10-mer CpG-containing DNA (CpG1: AGGCGTTTTT) and a 6-mer 5 0 -xCx-containing DNA (xCx4: TCGTTT) (Table 2, Figure S3A , bottom, Figure S5 ). According to the results of ITC and gel-filtration analyses, where variations at the first position were found to be tolerated (Table 1, Figure S2 ), the 5 0 -xCx2 and 5 0 -xCx3 DNA bound to TLR9 with essentially the same conformation as 5 0 -xCx1 DNA and contributed to the dimerization of TLR9 ( Figure S3A ). Because the first position of 5 0 -xCx DNA made less contact with TLR9, any bases, although it should be noted that adenine is less favored, can be accommodated at this position. The structure of BtTLR9 in complex with two DNAs exhibited essentially the same overall dimer structure and DNA recognition as EcTLR9 ( Figure S3B , right).
To confirm that the TLR9-5 0 -xCx DNA interactions identified by the structural analyses are actually important for binding, we prepared mutant mouse TLR9s harboring mutations at the 5 0 -xCx DNA binding site (F375A, F402A, Y535A, and Y537A in mouse TLR9) and examined their binding affinities for CpG-containing DNA and 5 0 -xCx-containing DNA by ITC (Table 3 ). The CpG DNA binding site mutant (W96A) resulted in a reduction of the binding of CpG-containing DNA but did not affect the binding of 5 0 -xCx-containing DNA. In contrast, all mutations of the 5 0 -xCx DNA binding site did not affect the binding of CpG-containing DNA but markedly attenuated the binding of 5 0 -xCx-containing DNA in the presence of CpG-containing DNA. These data reveal that TLR9 recognizes two different types of DNAs using two distinct binding sites.
Both the CpG and 5
0 -xCx DNAs Are Important for Efficient Activation of TLR9 in Various Cells In order to demonstrate that the 5 0 -xCx DNA binding site of TLR9 identified from by these biochemical, biophysical, and structural analyses is actually important for the activation of TLR9 in cells, we examined whether TLR9 can be activated by co-stimulation with two types of short DNA, each targeting one of the two binding sites, i.e., the CpG DNA and 5 0 -xCx DNA binding sites. We used a 10-mer CpG-containing DNA (AGGCGTTTTT) and a 6-mer 5 0 -xCx-containing DNA, and monitored activation of mouse TLR9 expressed in HEK293T cells by these DNAs using a luciferase reporter assay ( Figure 3A) . TLR9 was either not activated, or was poorly activated, after stimulation with either the CpG-containing DNA alone, or by co-stimulation with AGGGCTTTTT (as a negative control for the CpG-containing DNA) and the 5 0 -xCx DNA variants, indicating that the short CpG-containing DNA alone or the 5 0 -xCx-containing DNA alone cannot activate TLR9 efficiently in cells. Conversely, co-stimulation of the cells with the CpG-containing DNA and the 5 0 -xCxcontaining DNA variants cooperatively activated TLR9. In agreement with results of the ITC binding assay (Table 1) , we observed a similar sequence preference for TLR9: augmented activation of TLR9 was observed with the 6-mer DNAs possessing cytosine at the second position, but not in most of the DNAs with other bases at the second position. We also stimulated bone-marrowderived macrophages (BM-MCs) with CpG DNA and 5 0 -xCx DNAs and measured IL-12p40 production by ELISA ( Figure 3B) . We obtained results similar to those of the NF-kB reporter assay in HEK293 cells ( Figure 3A) ; CpG DNA or 5 0 -xCx DNA alone hardly produce IL-12p40, but co-stimulation greatly enhanced the IL-12p40 production. Those responses were all abolished in BM-MCs from Tlr9 À/À mice, indicating CpG DNA and 5 0 -xCx DNA specifically activate TLR9. Moreover, to assess mitogenactivated protein kinase and NF-kB signaling induced by TLR9 activation, we examined the phosphorylation of p65, Erk1/2, JNK1/2, and p38 in wild-type BM-MCs using western blotting ( Figure 3C ). Consistent with the reporter assay in HEK293T cells, co-stimulation with CpG DNA and 5 0 -TCG DNA strongly induced the phosphorylation of p65, and also elicited the phosphorylation of Erk1/2, JNK1/2, and p38. These data demonstrated the biological relevance of the 5 0 -xCx DNA binding site in TLR9-expressing cells. We also stimulated plasmacytoid dendritic cells (pDCs), which strongly induce interferon-a (IFN-a) secretion. In pDCs, TLR9-dependent IFN-a production by CpG DNA and 5 0 -xCx DNA was comparable to that by CpG DNA1585, which is known to strongly induce IFN-a ( Figure 3D ). These results demonstrated that synergistic stimulation with two types of DNAs is enough to activate TLR9 in various immune cells.
It should be mentioned that there was a strong preference for a thymidine base at the first position (5 0 -TCX DNA) that was observed in the cell-based assay ( Figures 3A and 3B) . In particular, marked activation of TLR9 was induced by a DNA containing the 5 0 -TCC sequence. A strong preference for 5 0 -TCX DNA over 5 0 -(A/G/C)CX DNA was also observed in gel-filtration chromatography, in which we used diluted concentrations of proteins and DNAs (in sub-micromolar range) to estimate the binding and dimerization efficacies of these DNAs ( Figure S6 ). The area of the dimer peak induced by 5 0 -TCG DNA saturated at low concentrations of DNA, while those induced by the other DNAs did not saturate within the concentration range tested, demonstrating that among 5 0 -xCx DNAs, 5 0 -TCX DNA induced TLR9 dimerization more efficiently than the others, although all of them induced TLR9 dimerization. This result is well correlated with the observed TLR9 activity in the cells.
These data showed that the 5 0 -xCx-containing DNA binding site in TLR9 plays an important role in the activation of TLR9, and that TLR9 can be activated by the cooperativity between the CpGcontaining DNA and the 5 0 -xCx-containing DNA (Figure 4 ).
DISCUSSION
In this study, we demonstrated that TLR9 has two DNA binding sites, namely a CpG DNA binding site and a 5 0 -xCx DNA binding site. The CpG DNA binding site is the first binding site in the protomer, and the 5 0 -xCx DNA binding site then cooperatively promotes the dimerization of TLR9 in the presence of CpG DNA, leading to efficient activation of TLR9. The sequence specificity of DNA that activates TLR9 has been extensively studied. Among them, a set of recent systematic studies by Jerala's group thoroughly defines the sequences that efficiently activate both human and mouse TLR9 (Pohar et al., 2015a; Pohar et al., 2015b; Pohar et al., 2017b) , 24-mer). They also predicted the existence of an additional DNA binding site, different from the CpG DNA binding site, revealed from our previous crystal structure of the complex between TLR9 and DNA1668_12-mer and demonstrated by mutation analyses that the TLR9 region corresponding to the nucleoside or chemical ligand binding sites in TLR7 and TLR8 is important for TLR9 activity: Alanine mutants of Tyr345, Phe375, Arg377, Phe402, Asp534, Tyr536, and Gly560 in human TLR9 exhibited reduced NF-kB activity when stimulated with ODN10104 (5 0 -TCGTCGTTTCGTCGTTTTGTCGTT-3 0 , 24-mer) (Pohar et al., 2017b) . Their results are complementary to our results in this study, where these residues are actually shown to be involved in 5 0 -xCx DNA recognition. Using mutagenesis, these workers also identified the residues, Gln346, Arg348, and Gln562 in human TLR9 (corresponding to Arg346, Lys348, and Lys563 in mouse TLR9), as being responsible for the difference in DNA sequence specificity between mouse and human TLR9. In particular, the difference of Gln346 (human TLR9) versus Arg346 (mouse TLR9) is a major and DNA containing various 5 0 -xCx (1 mM) was analyzed by Nanoluc reporter assay.
(B) BM-MCs from wild-type and Tlr9 À/À mice were stimulated with DNAs containing the indicated 5 0 -xCx DNAs (2.5, 5, 10, and 20 mM) and CpG-containing DNA
(1 mM), and IL-12p40 production was measured by ELISA. (C) Wild-type BM-MCs were stimulated by the indicated DNAs, and the phosphorylation of p65, Erk1/2, JNK1/2, and p38 was estimated by western blotting. (D) BM-pDCs from wild-type and Tlr9 À/À mice were stimulated with CpG-containing DNA (1 mM) and DNAs containing the indicated 5 0 -xCx (10 mM), and IFN-a production was measured by ELISA. Data in (A), (B), and (D) are presented as mean value ± SD from triplicates. Two-tailed Student's t test was used to evaluate the statistical significance versus CpG DNA-only groups (*p < 0.05, **p < 0.01, ***p < 0.005). Data shown in (C) are representative of three independent experiments. See also Figure S6 .
contributor to species specificity. Our study also revealed that these residues, corresponding to His346, Lys348, Arg562 in EcTLR9 and His345, Lys347, Gln560 in BtTLR9, are located at or near the 5 0 -xCx DNA binding site. In the crystal structure of EcTLR9 in complex with CpG-containing DNA and 5 0 -xCx-containing DNA, His346 and Lys348 were found to be in contact with the third and fourth nucleotides of 5 0 -xCx DNA. Although no noticeable specific interaction is formed between their side chains and DNA, the T nucleotide at the fourth position from the 5 0 end of the DNA that activates human TLR9 has been shown to be more preferred than the other (Pohar et al., 2015a) . Therefore, in human TLR9, these residues might be involved in specific recognition of the T nucleotide at the fourth position. Arg562 in EcTLR9 was present in the loop region of LRR18 and constituted part of the bottom of the 5 0 -xCx DNA binding pocket, protruding to the luminal side of the LRR structure of the other protomer of TLR9*, and did not directly interact with 5 0 -xCx DNA. Thus, this residue may possibly be involved in the recognition of the 3 0 extension of DNA bound to the CpG DNA binding site.
From our previous results, using the DNA1668_12-mer alone, which importantly does not contain the 5 0 -xCx motif, there was only weak dimerization and activation of EcTLR9 and BtTLR9 , whereas full-length DNA1668 (5 0 -TCCATG ACGTTCCTGATGCT-3 0 ) had much stronger activation of TLR9. This is likely because DNA1668 contains both motifs. On the other hand, dimerization of mouse TLR9 could be induced with CpG DNA alone, without a requirement for 5 0 -xCx binding, and this dimerization was stable enough to be observed by gel filtration chromatography, which is consistent with the fact that the mouse TLR9 has been reported to have a much lower requirement for the 5 0 -xCx sequence than human TLR9 (Pohar et al., 2015a; Pohar et al., 2015b; Pohar et al., 2017b) .
The fact that TLR9 has two DNA binding sites raises an intriguing question as to whether the two motifs, the CpG and 5 0 -xCx motifs, within one DNA or separate DNAs bind to TLR9. Previously, it was predicted that the former is plausible, where the first CpG motif on the 5 0 end (we refer to this as the 5 0 -xCx motif) binds the CpG binding site and the second CpG motif at the internal position binds the 5 0 -xCx binding site, identified in this study, to form a 2:2 complex with TLR9 (Pohar et al., 2017b) . However, the results from this study strongly suggests that the binding site is the opposite of this prediction, because only the 5 0 -xCx motif at the 5 0 end can bind to the 5 0 -xCx DNA binding site and the CpG motif cannot. The 5 0 -OH group of 5 0 -xCx-containing DNA made hydrogen bonds with D259 and Y345. The bottom of the 5 0 -xCx DNA binding site is tightly closed by the dimerization interaction between the two TLR9 protomers: the loop region of LRR8 and the concave surface of LRR10-12 in TLR9, and the loop region of LRR18-19* in TLR9*; thus, there is no gap between the two protomers through which DNA can pass. Indeed, the 5 0 -p-xCx-containing DNA exhibited extremely weak affinity compared with the 5 0 -xCx-containing DNA. Therefore, because the two DNAs in our structure were separated by the dimerization interface, a spacing at least a 10-mer or more between the two motifs is required in order to bind to the two binding sites using a single DNA. Based on the DNA sequences that have been optimized for human TLR9 (minH75: TCGT 7 CGT 12 ) (Pohar et al., 2015a) and mouse TLR9
(minM80:TCCT 3 CGT 15 ) (Pohar et al., 2015b) , both have a spacing less than a 10-mer between the two motifs; it would be reasonable to think that separate DNAs independently bind TLR9 to form a 2:2:2 complex with TLR9, in these cases (Figure 4) . Alternatively, two motifs in a single DNA molecule can bind to the two binding sites at the same time to form a 2:2 complex, depending on the spacing between the two motifs ( Figure 4) . Recently, it was reported that short ssDNAs containing a 5 0 -TCG motif could augment the activation of TLR9 synergistically with CpG-containing DNAs (Pohar et al., 2017a) , which agrees with, and reinforces, the activation model of TLR9 in this study.
The requirement of DNA with a 5 0 -xCx motif for TLR9 activation strongly suggests the importance of DNA processing. In fact, Chan et al. found that DNA digestion by DNase II is essential for class A CpG DNA sensing by TLR9; furthermore, the class A CpG DNA fragments formed by DNase II digestion that contain TCG sequences at the 5 0 end could induce efficient TLR9 signaling in bone-marrow-conventional dendritic cells (Chan et al., 2015) . This was consistent with our observation that CpG DNA and 5 0 -xCx DNA could stimulate not only BM-MCs but also pDCs.
Our study unifies the activation mechanisms of singlestranded nucleic acid sensors TLR7, TLR8, and TLR9, in which two ligands synergistically induce the activated dimer form of the receptors. These receptors utilize a same binding site at the middle of their LRR structures for guanosine (TLR7), uridine (TLR8), and the 5 0 -xCx DNA (TLR9) Zhang et al., 2016) . The C2 base in the 5 0 -xCx DNA is important for TLR9 binding, occupies the same position as guanosine (TLR7) and uridine (TLR8), and shares some features in the recognition mode, including hydrogen bonds with conserved Asp residues (Asp534* in EcTLR9) and stacking interactions with conserved Phe residues (Phe402 in EcTLR9). These ligands are simultaneously recognized by two protomers, and thus directly contribute to the dimerization of receptors. However, other binding sites, such as for ssRNA (TLR7 and TLR8) and CpG DNA (TLR9), differ in their positions and roles in receptor dimerization. The binding of CpG DNA at the N-terminal side of TLR9 alone can induce the dimerization of TLR9, although it is weak ; however, the binding of ssRNA to TLR7 or TLR8 cannot induce activated dimer form of the receptors, and therefore, ssRNAs are enhancers for uridine or guanosine binding Zhang et al., 2016) .
This study has established the structural basis that TLR9 binds not only to CpG DNA, but also to DNA containing the 5 0 -xCx motif, thus forming a stable 2: 2: 2 complex. This study offers a paradigm for the activation mechanism of TLR9, being regulated by cooperative binding of two types of DNAs with different sequence specificities for two distinct sites. These findings should promote the development of therapeutic agents that modulate the activity of TLR9.
STAR METHODS
Detailed methods are provided in the online version of this paper and include the following: Mice C57BL/6 mice were purchased from Japan SLC, Inc. The Tlr9 À/À mice were kind gifts from Prof. Shizuo Akira (Osaka University, Japan) (Hemmi et al., 2000) . For BM-MCs and BM-pDCs induction, bone marrow cells were collected from male mice.
METHOD DETAILS
Cell Culture S2 cells were maintained in Sf-900 II SFM medium (ThermoFisher Scientific) at 300 K with shaking at 100-110 rpm, and passaged every 2-3 day. HEK293T cells were cultured in RPMI1640 (nakarai tesque) complemented with 10% FBS, penicillin-streptomycinGlutamine (GIBCO), and 50 mM 2-ME (Nacalai tesque) at 37 C under 5% CO 2 .
Protein Expression, Purification, and Crystallization The recombinant Z-loop cleaved form of Toll-like receptor 9 (TLR9) proteins from horse (EcTLR9), bovine (BtTLR9), and mouse (MmTLR9) were prepared as described previously and used for gel-filtration chromatography, ITC, and crystallographic analyses. For crystallization, proteins were expressed in the presence of kifunensine (1.8 mg mL -1 ) and subsequently trimmed of their polysaccharide chains using endoHf. To prepare the DNA complexes with TLR9, approximately two fold excesses of a CpGcontaining DNA and a 5 0 -xCx-containing DNA were added to the protein solutions. Crystallization experiments were performed using a sitting-drop vapor-diffusion method at 293 K. The crystallization droplets were made by mixing an equivalent volume of protein solution and reservoir solution typically of 0.5-1.0 mL volume. The crystallization conditions are summarized in Table S1 .
Data Collection and Structure Determination
Diffraction datasets were collected on beamlines PF-AR NE3A (Ibaraki, Japan) and SPring-8 BL41XU (Hyogo, Japan) under cryogenic condition at 100 K. Crystals were soaked in a cryoprotectant solution summarized in Table S1 and then flash-cooled under cold gas stream. The diffraction datasets were processed using the HKL2000 package (Otwinowski and Minor, 1997) or XDS (Kabsch, 2010) . The initial phases for the EcTLR9 and BtTLR9 structures were determined by the molecular replacement method using the Molrep (Vagin and Teplyakov, 2010) program using the corresponding TLR9 structures (PDB IDs: 3WPC and 3WPE). The model was further refined with stepwise cycles of manual model building using the COOT program (Emsley and Cowtan, 2004 ) and restrained refinement using REFMAC (Murshudov et al., 1997) until the R factor converged. Ligand molecules, N-glycans, and water molecules were modeled into the electron density maps at later cycles in the refinement. The quality of the final structure was evaluated with MolProbity (Chen et al., 2010) . In the structures of EcTLR9/CpG1/xCx1, EcTLR9/CpG1/xCx2, EcTLR9/CpG1/xCx3 and BtTLR9/CpG1/xCx4, 99.4%, 99.3%, 99.3% and 98.8% of the residues were in Ramachandran favored or allowed regions, respectively. The statistics of the data collection and refinement are summarized in Table 2 . The figures representing structures were prepared with CueMol (http://www.cuemol.org).
